ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Nuvectis Pharma Inc

Nuvectis Pharma Inc (NVCT)

4.735
0.085
( 1.83% )
Updated: 10:28:15

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
4.735
Bid
4.64
Ask
4.85
Volume
12,791
4.55 Day's Range 4.84
4.44 52 Week Range 12.10
Market Cap
Previous Close
4.65
Open
4.72
Last Trade
45
@
4.745
Last Trade Time
10:31:17
Financial Volume
$ 61,273
VWAP
4.7904
Average Volume (3m)
180,558
Shares Outstanding
19,320,973
Dividend Yield
-
PE Ratio
-4.04
Earnings Per Share (EPS)
-1.15
Revenue
-
Net Profit
-22.26M

About Nuvectis Pharma Inc

Nuvectis Pharma Inc is a biopharmaceutical company. Nuvectis Pharma Inc is a biopharmaceutical company.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Nuvectis Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NVCT. The last closing price for Nuvectis Pharma was $4.65. Over the last year, Nuvectis Pharma shares have traded in a share price range of $ 4.44 to $ 12.10.

Nuvectis Pharma currently has 19,320,973 shares outstanding. The market capitalization of Nuvectis Pharma is $89.84 million. Nuvectis Pharma has a price to earnings ratio (PE ratio) of -4.04.

NVCT Latest News

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

Nuvectis Pharma (NASDAQ: NVCT) continues to make strides in precision oncology, gaining momentum following presentations last week at the AACR-NCI-EORTC Symposium where its drug candidate NXP900...

PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch

With its focus on targeting well-defined subgroups by inhibiting SRC/YES1 kinases in Non Small-Cell Lung Cancer patients resistant to EGFR and ALK targeted therapies, Nuvectis Pharmaโ€™s NXP900...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.025-0.5252100840344.764.954.441033824.58660818CS
4-0.485-9.291187739465.225.47994.44928764.7835518CS
12-1.525-24.36102236426.2611.84.441805586.78049595CS
26-2.475-34.32732316237.2111.84.441295846.72044732CS
52-3.775-44.35957696838.5112.14.441122037.19228803CS
1560.78519.87341772153.9520.923.081888637.84114017CS
2600.78519.87341772153.9520.923.081888637.84114017CS

NVCT - Frequently Asked Questions (FAQ)

What is the current Nuvectis Pharma share price?
The current share price of Nuvectis Pharma is $ 4.735
How many Nuvectis Pharma shares are in issue?
Nuvectis Pharma has 19,320,973 shares in issue
What is the market cap of Nuvectis Pharma?
The market capitalisation of Nuvectis Pharma is USD 89.84M
What is the 1 year trading range for Nuvectis Pharma share price?
Nuvectis Pharma has traded in the range of $ 4.44 to $ 12.10 during the past year
What is the PE ratio of Nuvectis Pharma?
The price to earnings ratio of Nuvectis Pharma is -4.04
What is the reporting currency for Nuvectis Pharma?
Nuvectis Pharma reports financial results in USD
What is the latest annual profit for Nuvectis Pharma?
The latest annual profit of Nuvectis Pharma is USD -22.26M
What is the registered address of Nuvectis Pharma?
The registered address for Nuvectis Pharma is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Nuvectis Pharma website address?
The website address for Nuvectis Pharma is www.nuvectis.com
Which industry sector does Nuvectis Pharma operate in?
Nuvectis Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MGIHMillennium Group International Holdings Ltd
$ 4.1097
(168.61%)
59.39M
SPRCSciSparc Ltd
$ 0.557999
(152.26%)
172.97M
SKKSKK Holdings Limited
$ 1.79
(139.30%)
9.23M
ZCARZoomcar Holdings Inc
$ 2.73
(90.91%)
44.96M
PDYNPalladyne AI Corporation
$ 8.11
(64.17%)
35.61M
NEUPNeuphoria Therapeutics Inc
$ 4.10
(-38.16%)
315.75k
GTIGraphjet Technology
$ 0.3916
(-35.80%)
10.12M
BAOSBaosheng Media Group Holdings Ltd
$ 4.68
(-34.08%)
905.81k
SVRESaverOne 2014 Ltd
$ 1.06
(-29.80%)
715.3k
HOURHour Loop Inc
$ 3.1197
(-29.10%)
4.1M
SPRCSciSparc Ltd
$ 0.557999
(152.26%)
172.97M
COEPCoeptis Therapeutics Holdings Inc
$ 0.2159
(52.04%)
150.63M
SMXSMX Security Matters Public Company
$ 0.2866
(31.47%)
89.71M
XTIAXTI Aerospace Inc
$ 0.0439
(11.99%)
83.31M
RGTIRigetti Computing Inc
$ 13.875
(22.25%)
75.98M

NVCT Discussion

View Posts
gail gail 1 month ago
grabbed some on the dip
๐Ÿ‘๏ธ0
Monksdream Monksdream 4 months ago
NVCT under $10
๐Ÿ‘๏ธ0
Monksdream Monksdream 6 months ago
NVCT under $10
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
NVCT under $10
๐Ÿ‘๏ธ0
Monksdream Monksdream 10 months ago
NVCT 10Q due March 6
๐Ÿ‘๏ธ0
Monksdream Monksdream 12 months ago
NVCT a bounce
๐Ÿ‘๏ธ0
conix conix 3 years ago
NVCT HIGHLIGHTS:

*Recently completed Initial Public Offering - $5.00 Per share
*2 Precision Cancer medicines in development - ovarian and triple negative breast
*Data flow throughout 2022
*CEO with multiple success stories in life science sector to $billion dollar market caps
*Analysts project a $66 billion precision medicines market for 2021; In 6 years, this number is expected to top $140 billion

Nuvectis Pharma Inc - Company Background:

Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. The Company is currently developing two drug candidates: NXP800, a clinical-stage HSF1 pathway inhibitor currently in a Phase 1 study in patients with advanced solid tumors, and NXP900, a novel SRC/YES1 kinase inhibitor currently in preclinical development with IND-enabling studies ongoing.

Market Capitalization: $225 million
Range - 52 week: $3.08 - $20.75
Current Price: $20.44
Trades on: Nasdaq Capital Market
Ticker Symbol: NVCT

website: nuvectis.com
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 3 years ago
wow from $3 to almost $21
๐Ÿ‘๏ธ0
ipo_dude ipo_dude 3 years ago
$27 we come
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 3 years ago
WOW $7 MOVE 3-10


CONGRAT$ NVCT
๐Ÿ‘๏ธ0
spindog spindog 3 years ago
I feel the same
๐Ÿ‘๏ธ0
kkballa kkballa 3 years ago
hmmm.
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock